Form 4: Guardant Health Executive Helmy Eltoukhy Reports Stock Transactions
SEC Form 4 Filing
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reports transactions involving common stock and restricted stock units.
Summary
- Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On December 31, 2024, 11,462 shares of common stock were acquired through the vesting of restricted stock units, and 5,809 shares were disposed of to cover tax withholding obligations at a price of $30.55.
- On January 1, 2025, 94,555 shares of common stock were acquired through the vesting of restricted stock units, and 43,309 shares were disposed of to cover tax withholding obligations at a price of $30.55.
- Following these transactions, Eltoukhy directly owns 2,361,165 shares of Guardant Health common stock and 191,978 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Positives
- The vesting of restricted stock units indicates a continued alignment of the executive's interests with the company's performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive incentives with long-term shareholder value.
- Tax withholding practices related to vesting are standard procedure across publicly traded companies.
- Comparable companies such as Exact Sciences and Illumina also have executives who regularly report stock transactions via Form 4 filings.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive stock ownership.
- The vesting of restricted stock units incentivizes the executive to work towards the long-term success of the company.
Key Dates
| Date | Description |
|---|---|
| March 18, 2024 | Date of grant for restricted stock unit awards. |
| December 31, 2024 | Vesting of restricted stock units and tax withholding. |
| January 1, 2025 | Vesting of restricted stock units and tax withholding. |
| January 3, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.